Myasthenia Gravis Life Expectancy and Disease Course

Disease Course of Myasthenia Gravis 

In myasthenia gravis (MG), muscle weakness often fluctuates throughout the day. Symptoms typically improve with rest and may worsen with physical activity, prolonged use of affected muscles, illness, stress, or fatigue. Many people with MG feel stronger earlier in the day and weaker later in the evening.

Symptoms often worsen gradually during the first 1 to 3 years after disease onset before stabilizing with treatment. In about 15% of people, MG remains limited to the eye muscles (ocular MG). However, most patients eventually develop generalized MG, which affects muscles involved in speaking, swallowing, limb movement, or breathing.

Most people with MG are able to maintain mobility and independence with appropriate treatment. While symptom severity varies, many patients continue to work, exercise, and participate in daily activities.

Some people with MG experience remission, meaning symptoms partially or completely disappear for a period of time. Remission may last for several years and can occur more than once during a person’s lifetime. In some cases, long-term or permanent remission is possible.

MG can affect physical, emotional, social, and financial well-being, particularly when symptoms interfere with daily activities or employment.

Factors associated with reduced quality of life in people with MG include: 

• Impaired mobility
• Depression
• Low income
• Job loss
• Obesity

Myasthenia Gravis Life Expectancy

Although there is currently no cure for myasthenia gravis, modern treatments can effectively control symptoms in many patients. As a result, most people with MG have a normal or near-normal life expectancy. Advances in diagnosis, intensive care, and immunotherapy have significantly improved outcomes for people living with MG over the past several decades.

Serious complications can still occur, particularly during a myasthenic crisis, which causes severe respiratory muscle weakness and requires emergency medical treatment. Early diagnosis, ongoing treatment, infection prevention, and regular medical care can significantly reduce the risk of complications.

Health Conditions Associated With an Increased Risk of Complications in MG

Several studies suggest that the following factors may increase death risk:

• Stroke
• Chronic obstructive pulmonary disease (COPD)
• Pneumonia
• Flu
• Diabetes
• Irregular heart rhythm (atrial fibrillation)
• High blood fat levels (hyperlipidemia)
• Heart attack (myocardial infarction)
• Malignant tumor

Common treatments for MG include acetylcholinesterase inhibitors, corticosteroids, immunosuppressants, intravenous immunoglobulin (IVIG), plasma exchange, biologic therapies, and thymectomy in selected patients.